| Size | Price | Stock |
|---|---|---|
| 5mg | $75 | In-stock |
| 10mg | $130 | In-stock |
| 25mg | $290 | In-stock |
| 50mg | $510 | In-stock |
| 100mg | $890 | In-stock |
| 200 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-12443 |
| M.Wt: | 419.45 |
| Formula: | C22H22FN7O |
| Purity: | >98 % |
| Solubility: |
PF-5006739 is a potent and selective inhibitor of CK1δ/ε with IC50s of 3.9 nM and 17.0 nM, respectively. PF-5006739 is a potential therapeutic agent for a range of psychiatric disorders with low nanomolar in vitro potency for CK1δ/ε and high kinome selectivity. PF-5006739 attenuats opioid agent-seeking behavior in a rodent operant reinstatement model in animals in a dose-dependent manner[1]. PF-5006739 improves glucose tolerance in both diet-induced obesity (DIO) and genetic (ob/ob) mice models of obesity[2].
IC50 & Target:IC50: 3.9 nM (CK1δ) and 17.0 nM (CK1ε)[1]
In Vitro:PF-5006739 has low nM in vitro potency for CK1δ/ε (IC50 = 3.9 and 17 nM)[1].
PF-5006739 (0.4-50 μM, 5 d) causes a rapid and dose-dependent induction of mPER2::luc bioluminescence in WAT tissue explants[2].
In Vivo:PF-5006739 (10mg/kg/day, s.c., once daily) significantly improves blood glucose profiles in DIO mice[2].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.